Showing results (91-100 of 330) with videos related to
Sort By:
Pageof 33
Drugs|April 2, 2026
Oral Gut-Restricted Targeted Therapy for IBD: A Pipeline ReviewJoana Roseira, Marianne Hupé, Yuhong Yuan, et al.Alimentary Pharmacology & Therapeutics|May 7, 2025
The Effectiveness of Medical Therapies for Joint, Skin and Eye Extraintestinal Manifestations in IBD-An Umbrella ReviewOlga M Nardone, Nurulamin M Noor, Aniruddh Prabhu, et al.British Journal of Pharmacology|July 28, 2004
Intestinal Na+-K+-ATPase activity and molecular events downstream of interferon-gamma receptor stimulationFernando Magro, Sónia Fraga, Tomé Ribeiro, et al.Inflammatory Bowel Diseases|August 11, 2016
A Systematic Review on Infliximab and Adalimumab Drug Monitoring: Levels, Clinical Outcomes and AssaysFilipa Silva-Ferreira, Joana Afonso, Pedro Pinto-Lopes, et al.Journal of Crohn'S & Colitis|August 12, 2025
Longitudinal Profiles of Fecal Calprotectin and C-Reactive Protein in Relation to Outcomes in Crohn's Disease Patients on InfliximabFernando Magro, Beatriz Domingues, Maria Manuela Estevinho, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|August 22, 2015
Short- and long-term regulation of intestinal Na+/H+ exchange by Toll-like receptors TLR4 and TLR5José Miguel Cabral, Daniela Grácio, Patrício Soares-da-Silva, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|January 9, 2016
Role of epithelial ion transports in inflammatory bowel diseaseDiogo Magalhães, José Miguel Cabral, Patrício Soares-da-Silva, et al.United European Gastroenterology Journal|June 15, 2023
How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?-A prospective studyFernando Magro, Maria Manuela Estevinho, Gaia Catalano, et al.ARP Rheumatology|July 10, 2022
Musculoskeletal manifestations in a Portuguese cohort of 235 inflammatory bowel disease patientsBruno Miguel Fernandes, Diana Rosa-Gonçalves, Fernando Magro, et al.European Journal of Gastroenterology & Hepatology|July 3, 2023
Vaccines - beliefs and concerns: the voice of patients with inflammatory immunomediated diseasesCândida Abreu, António Martins, Elsa Branco, et al.Pageof 33